The use of snake venom-derived compounds for new functional diagnostic test kits in the field of haemostasis

35Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Pentapharm Ltd. has a long tradition of producing and proceeding snake venom components as APIs and tools in pharmaceutical and diagnostic applications, beginning with the snake venom-derived product Reptilase® about 60 years ago. In recent years diagnostic test kits in the field of haemostasis have been developed, like Pefakit® APC-R Factor V Leiden and Pefakit® PiCT®, which make use of one or more snake venom compounds as key reactants. The venom-derived compounds are responsible for many outstanding properties of these tests and account for their top ranking performance qualities confirmed in non-clinical and clinical studies. Both tests are on the market in Europe. Pefakit® APC-R Factor V Leiden is also marketed in the US since January 2005. Research on snake venom-derived compounds for diagnostic and pharmaceutical use is ongoing. Copyright © 2005 S. Karger AG.

Cite

CITATION STYLE

APA

Schöni, R. (2006). The use of snake venom-derived compounds for new functional diagnostic test kits in the field of haemostasis. In Pathophysiology of Haemostasis and Thrombosis (Vol. 34, pp. 234–240). https://doi.org/10.1159/000092430

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free